Haug, L.S., Østvold, A.C., Cowburn, R.F., Garlind, A., Winblad, B., Bogdanovich and Walaas, S.I. (1996): Decreased Inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and correlation to pathological severity. Neurodegeneration 5 (2), 169-176
Haug, L.S., Østvold, A.C., Torgner, I., Roberg, B., Dvorakova, L. and Walaas, S.I. (1997): Type I IP3-receptor and phosphate activated glutaminase are highly enriched in neurons as compared to glia cells in rat neostriatum. Neurochemistry: Cellular, Molecular and Clinical Aspects (A.Teelken, and J. Korf, eds.) Plenum Press, New York, pp.389-394
Haug, L.S., Østvold, A.C., Torgner, I. Roberg, B., Dvorakova, L. Stastny, F. and Walaas, S.I. (1998): Intracerebroventricular administration of quinolinic acid induces a selective decrease of inositol(1,4,5)-trisphosphate receptor in rat brain. Neurochem. Int. 33, 109-119
Haug, L.S., Jensen, V., Hvalby, Ø., Walaas, S.I. and Østvold, A.C. (1999):
Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic nucleotide-dependent kinases in vitro and in rat cerebellar slices in situ. J.Biol. Chem. 274 (11), 7467-7473
Borgne, A., Østvold, A.C., Flament, S. and Meijer, L. (1999): Intra-MPF phosphorylation of cyclin B at the prophase/metaphase transition.J.Biol. Chem. 274 (17), 11977-11987
Dahl, C., Haug, L.S., Spilsberg, B. Johansen, J., Østvold, A.C. and Diemer, N.H. (1999): Reduced [3H]IP3 binding but unchanged IP3 receptor levels in the rat hippocanpus CA1 region following transient global ischemia and tolerance induction. Neurochem. Int. 36, 379-388
Haug, L.S., Walaas, S.I. and Østvold, A.C.(2000): Degradation of the Type I Inositol 1,4,5-Trisphosphate Receptor by Caspase-3 in SHSY5Y Neuroblastoma cells Undergoing Apoptosis. J. Neurochem. 75 (5), 1852-1861
Haug, L.S. and Østvold, A.C.(2000): Regulation of type I IP3 receptors and neurodegeneration. Current Topics in Biochemical Research Vol.2, 77-89
Østvold, A.C., Norum, J.H., Mathiesen; S., Wanvik, B., Sefland, I and Grundt, K. (2001): Molecular cloning of a mammalian nuclear phosphoprotein NUCKS which serves as substrate for Cdk1 in vivo. Eur. J. Biochem. 268, 2430-2440
Johannesen,L.E., Haugen, K.E., Østvold, A.C., Stang, E. and Madshus, I.H.(2001): Heterodimerisation of the epidermal growth factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms. Biochem.J. 356 (1), 87-96
Oksvold, M.P., Huitfeldt, H.S., Østvold, A.C. and Skarpen, E. (2002): UV Induces tyrosin kinase- independent internalization and endosome arrest of the EGF receptor.J. Cell Sci. 115(Pt4), 793-803
Slagvold, H.H., Østvold, A.C., Fallgren, Å.B. and Paulsen, R.E. (2002): Transcription Factor and apoptose initiator NGFI-B is a substrate for the mitogen activated protein kinase ERK. BBRC 291(5), 1146-1150
Grundt, K., Skjeldal, L., Anthonsen, H.W., Skauge, T., Huidtfeldt, H. and Østvold, A.C. (2002): A putative DNA binding domain in the NUCKS protein. Archives of Biochemistry and Biophysics 407, 168-175
Grundt, K., Vågslid Haga, I., Drosos, Y., Aleporou-Marinou, V., Wanvik, B. and Østvold, A.C. (2004): Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species. Biochem. Biophys. Res. Comm. 323, 796-801
Rosseland C.M., Wierød, L., Oksvold, M.P., Werner, H., Østvold, A.C., Thoresen, G.H., Paulsen, R.E., Huitfeldt, H.S., Skarpen, E. (2005): Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. Hepatology 42(1), 200-207
Grundt, K., Haga, I.V., and Østvold Anne Carine (2007): Identification and characterization of two putative nuclear localization signals (NLS) in the DNA-binding protein NUCKS. BBA Mol. Cell Res. 1773, 1398-1406
Sargent, L., Ensell, M.X., Ostvold, A.C., Baldwin, K.T., Kashon, M.L., Lowry, D.T, Senft J.R., Jefferson, A.M., Johnson, R.C., Li, Z., Tyson, F.L. and Reynolds, S.H. (2008): Chromosomal changes in high and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicology and Applied Pharmacology,233, 81-91
Drosos Y., Kouloukoussa M., Østvold A.C., Grundt, K., Goutas, N., Vlachodimitropoulos D., Havaki, S., Kollia, P., Kittas C., Marinos, E. and Alepourou-Marinou, V. (2009): NUCKS overexpression in breast cancer. Cancer Cell International 10, 9-19.